Tectonic Therapeutic, Inc.
TECXBiological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0001681087
Revenue FY2025
—
Net Income
$(74.0M)
EPS (Basic)
$-4.05
Net Margin
—
ROE
-29.5%
Total Equity
$251.0M
Shares Out
20M
Tectonic Therapeutic, Inc. — Biological Products, (No Diagnostic Substances). Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2017–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 3 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Baker Bros. Advisors
Baker Bros. Advisors
$20.9M
0.1%
—
OrbiMed Advisors
OrbiMed Advisors
$7.8M
0.0%
—
Alps Advisors
Alps Advisors
$0.7M
0.0%
+25.3%
Insider Transactions
Reading stored insider transactions…